Advertisement

Topics

Atomwise Inc. Company Profile

15:28 EDT 21st August 2018 | BioPortfolio

Atomwise uses artificial intelligence to help discover new medicines and agricultural compounds. Its groundbreaking AtomNet technology reasons like a human chemist, using powerful deep learning algorithms and supercomputers to analyze millions of potential molecules each day. Atomwise has launched more than 50 discovery projects in partnership with the world’s top research companies and universities. Now, through its many partnering programs and robust venture funding, Atomwise is actively seeking new collaborators to address the global health challenges of our time using the power of artificial intelligence.


News Articles [8 Associated News Articles listed on BioPortfolio]

Atomwise Raises $45M To Grow AI-Driven Drug Discovery Business

Atomwise, a San Francisco startup that’s using artificial intelligence to hunt for compounds that could make effective new drugs, announced today that it raised a $45 million Series A round. The sma...

AI firm Atomwise secures $45mm Series A round

Atomwise Inc. (AI using deep neural networks for drug discovery) closed a $45mm Series A round co-led by Monsanto Growth Ventures, DCVC (Data Collective), and B Capital Group. Returning backers Y Comb...

Atomwise Awards Support Academic Researchers

Atomwise, Inc., a leader in using artificial intelligence (AI) for drug screening and design, is now accepting applications for their 2018 Artificial Intelligence Molecular Screen (AIMS) awards. The a...

Atomwise Raises $45M for Artificial Intelligence Platform for Drug Discovery

Atomwise, a San Francisco, CA-based company that develops artificial intelligence systems for drug discovery has raised $45 million in Series A funding led by Monsanto Growth Ventures, B Capital Group...

Atomwise Expands its Groundbreaking Artificial Intelligence Screening Program to Support Academic Projects Worldwide

The post Atomwise Expands its Groundbreaking Artificial Intelligence Screening Program to Support Academic Projects Worldwide appeared first on SynBioBeta.

AI drug discovery company Atomwise raises $51M series A

Atomwise Raises $45 Million Series A to Become the Preferred Artificial Intelligence Partner ...

Press:For AtomwiseEmily Rose, (212) 738-6066Emily.Rose@edelman.com Read more...

Atomwise Raises $45 Million Series A to Become the Preferred Artificial Intelligence Partner for the Global Pharmaceutical Industry

Atomwise Inc. today announced it has raised $45 million of growth funding, led by Monsanto Growth Ventures, DCVC (Data Collective), and B Capital Group, in support of its mission ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Atomwise Inc.

Atomwise uses artificial intelligence to help discover new medicines and agricultural compounds. Its groundbreaking AtomNet technology reasons like a human chemist, using powerful...

More Information about "Atomwise Inc." on BioPortfolio

We have published hundreds of Atomwise Inc. news stories on BioPortfolio along with dozens of Atomwise Inc. Clinical Trials and PubMed Articles about Atomwise Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Atomwise Inc. Companies in our database. You can also find out about relevant Atomwise Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record